EXECUTIVE ENGAGEMENTS
POOL
503
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
101
Interactions with Platform & by Email
PARTICIPANTS
22
Unique # Participated
VALIDATIONS
8
Responses Validated*
COMPANIES
58
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
105
PAGES
193
EDITION
6
PRICE
USD 4950
CODE
MCP16689
*Engagement stats are ongoing and dynamic
Login to access data silos
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Photopheresis Products estimated at US$320.1 Million in the year 2020, is projected to reach a revised size of US$456.5 Million by 2027, growing at aCAGR of 5.2% over the period 2020-2027. Open System, one of the segments analyzed in the report, is projected to record 5% CAGR and reach US$127.7 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Closed System segment is readjusted to a revised 5.3% CAGR for the next 7-year period.
The Photopheresis Products market in the U.S. is estimated at US$94.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$81 Million by the year 2027 trailing a CAGR of 5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.8% and 4.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.
SELECT PLAYERS
Fresenius Kabi AG; Haemonetics Corporation; MacoPharma SA; Mallinckrodt plc; Terumo Corporation
SEGMENTS
» Application (Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections, Autoimmune Diseases) » Product Type (Open System, Closed System)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Photopheresis Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Photopheresis Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Photopheresis Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Open System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Open System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Open System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Closed System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Closed System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Closed System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Cutaneous T-cell Lymphoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cutaneous T-cell Lymphoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cutaneous T-cell Lymphoma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Graft versus Host Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Graft versus Host Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Graft versus Host Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Transplant Rejections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Transplant Rejections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Transplant Rejections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Autoimmune Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Photopheresis Products by Product Type - Open System and Closed System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Photopheresis Products by Product Type - Open System and Closed System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Photopheresis Products by Product Type - Percentage Breakdown of Value Sales for Open System and Closed System for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Photopheresis Products by Application - Percentage Breakdown of Value Sales for Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Photopheresis Products by Product Type - Open System and Closed System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Photopheresis Products by Product Type - Open System and Closed System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Photopheresis Products by Product Type - Percentage Breakdown of Value Sales for Open System and Closed System for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Photopheresis Products by Application - Percentage Breakdown of Value Sales for Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Photopheresis Products by Product Type - Open System and Closed System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Photopheresis Products by Product Type - Open System and Closed System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Photopheresis Products by Product Type - Percentage Breakdown of Value Sales for Open System and Closed System for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Photopheresis Products by Application - Percentage Breakdown of Value Sales for Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Photopheresis Products by Product Type - Open System and Closed System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Photopheresis Products by Product Type - Open System and Closed System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Photopheresis Products by Product Type - Percentage Breakdown of Value Sales for Open System and Closed System for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Photopheresis Products by Application - Percentage Breakdown of Value Sales for Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Photopheresis Products by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Photopheresis Products by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Photopheresis Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Photopheresis Products by Product Type - Open System and Closed System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Photopheresis Products by Product Type - Open System and Closed System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Photopheresis Products by Product Type - Percentage Breakdown of Value Sales for Open System and Closed System for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Photopheresis Products by Application - Percentage Breakdown of Value Sales for Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Photopheresis Products by Product Type - Open System and Closed System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Photopheresis Products by Product Type - Open System and Closed System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Photopheresis Products by Product Type - Percentage Breakdown of Value Sales for Open System and Closed System for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Photopheresis Products by Application - Percentage Breakdown of Value Sales for Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Photopheresis Products by Product Type - Open System and Closed System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Photopheresis Products by Product Type - Open System and Closed System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Photopheresis Products by Product Type - Percentage Breakdown of Value Sales for Open System and Closed System for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Photopheresis Products by Application - Percentage Breakdown of Value Sales for Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Photopheresis Products by Product Type - Open System and Closed System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Photopheresis Products by Product Type - Open System and Closed System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Photopheresis Products by Product Type - Percentage Breakdown of Value Sales for Open System and Closed System for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Photopheresis Products by Application - Percentage Breakdown of Value Sales for Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Photopheresis Products by Product Type - Open System and Closed System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Photopheresis Products by Product Type - Open System and Closed System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Photopheresis Products by Product Type - Percentage Breakdown of Value Sales for Open System and Closed System for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Photopheresis Products by Application - Percentage Breakdown of Value Sales for Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Photopheresis Products by Product Type - Open System and Closed System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Photopheresis Products by Product Type - Open System and Closed System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Photopheresis Products by Product Type - Percentage Breakdown of Value Sales for Open System and Closed System for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Photopheresis Products by Application - Percentage Breakdown of Value Sales for Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Photopheresis Products by Product Type - Open System and Closed System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Photopheresis Products by Product Type - Open System and Closed System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Photopheresis Products by Product Type - Percentage Breakdown of Value Sales for Open System and Closed System for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Photopheresis Products by Application - Percentage Breakdown of Value Sales for Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Photopheresis Products by Product Type - Open System and Closed System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Photopheresis Products by Product Type - Open System and Closed System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Photopheresis Products by Product Type - Percentage Breakdown of Value Sales for Open System and Closed System for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Photopheresis Products by Application - Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Photopheresis Products by Application - Percentage Breakdown of Value Sales for Cutaneous T-cell Lymphoma, Graft versus Host Disease, Transplant Rejections and Autoimmune Diseases for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 58 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com